20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with arginine in 2 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolad, I; Delafontaine, P | 1 |
| Blanton, A; Hercule, H; Nsaif, R; Oyekan, A | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and arginine
| Article | Year |
|---|---|
Endothelial dysfunction: its role in hypertensive coronary disease.
Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants | 2005 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and arginine
| Article | Year |
|---|---|
Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.
Topics: Amidines; Animals; Arginine; Blood Pressure; Bradykinin; Cyclosporine; Cytochrome P-450 Enzyme System; Endothelin-1; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Nitric Oxide; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Triazoles | 2006 |